Vimarsana
Biggest News Aggregation in the World

Page 8 - Sny News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sny. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sny Today - Breaking & Trending Today

Polestar welcomes Geely's long-term commitment to its development and growth as an independent exclusive performance brand - Vimarsana News

Polestar welcomes Geely's long-term commitment to its development and growth as an independent exclusive performance brand

Polestar Automotive Holding UK PLC (Nasdaq: PSNY), the Swedish electric performance car brand, welcomes Geely Sweden Holding as a potential direct new shareholder. Volvo Cars is evaluating a potential adjustment to its shareholding in Polestar including a distribution of shares to its shareholders, with Geely Sweden Holding being the primary recipient. Volvo Cars will remain a strategic partner in areas across R&D, manufacturing, after sales and commercial. Polestar has made significant p...

Teva Stock Gains. The Company Will Divest Drug Ingredients Business. - Vimarsana News

Teva Stock Gains. The Company Will Divest Drug Ingredients Business.

Teva has struggled for years with enormous debts and litigation over its role in the opioid crisis.

Big Pharma Reports Earnings Soon. Lilly and Pfizer Aren't the Same. - Vimarsana News

Big Pharma Reports Earnings Soon. Lilly and Pfizer Aren't the Same.

While the S&P 500 rose 24% in 2023, the S&P 500 Pharmaceuticals industry index slipped 2.2%. Lilly and Novo Nordisk were the exceptions in a slumping...

Sanofi (NASDAQ:SNY) Sees Large Volume Increase - Vimarsana News

Sanofi (NASDAQ:SNY) Sees Large Volume Increase

Shares of Sanofi (NASDAQ:SNY – Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 1,780,053 shares traded hands during mid-day trading, an increase of 10% from the previous session’s volume of 1,624,022 shares.The stock last traded at $50.01 and had previously closed at $50.83. Wall Street Analysts Forecast Growth Several equities research analysts […]

Regeneron, Sanofi Get FDA OK for Esophagus Inflammation Treatment in Younger Children - Vimarsana News

Regeneron, Sanofi Get FDA OK for Esophagus Inflammation Treatment in Younger Children

By Ben Glickman Regeneron Pharmaceuticals and Sanofi's Dupilumab received approval from the U.S. Food and Drug Administration for a treatment of an esophagus...